230 related articles for article (PubMed ID: 11544480)
21. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.
Hayashi Y; Bardsley MR; Toyomasu Y; Milosavljevic S; Gajdos GB; Choi KM; Reid-Lombardo KM; Kendrick ML; Bingener-Casey J; Tang CM; Sicklick JK; Gibbons SJ; Farrugia G; Taguchi T; Gupta A; Rubin BP; Fletcher JA; Ramachandran A; Ordog T
Gastroenterology; 2015 Aug; 149(2):420-32.e16. PubMed ID: 25865047
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor β and Ras/MEK/ERK signaling regulate the expression level of a novel tumor suppressor Lefty.
Miyata N; Azuma T; Hozawa S; Higuchi H; Yokoyama A; Kabashima A; Igarashi T; Saeki K; Hibi T
Pancreas; 2012 Jul; 41(5):745-52. PubMed ID: 22441145
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-181a suppresses salivary adenoid cystic carcinoma metastasis by targeting MAPK-Snai2 pathway.
He Q; Zhou X; Li S; Jin Y; Chen Z; Chen D; Cai Y; Liu Z; Zhao T; Wang A
Biochim Biophys Acta; 2013 Nov; 1830(11):5258-66. PubMed ID: 23911747
[TBL] [Abstract][Full Text] [Related]
24. Role of LIM and SH3 protein 1 (LASP1) in the metastatic dissemination of medulloblastoma.
Traenka C; Remke M; Korshunov A; Bender S; Hielscher T; Northcott PA; Witt H; Ryzhova M; Felsberg J; Benner A; Riester S; Scheurlen W; Grunewald TG; von Deimling A; Kulozik AE; Reifenberger G; Taylor MD; Lichter P; Butt E; Pfister SM
Cancer Res; 2010 Oct; 70(20):8003-14. PubMed ID: 20924110
[TBL] [Abstract][Full Text] [Related]
25. Foretinib is effective therapy for metastatic sonic hedgehog medulloblastoma.
Faria CC; Golbourn BJ; Dubuc AM; Remke M; Diaz RJ; Agnihotri S; Luck A; Sabha N; Olsen S; Wu X; Garzia L; Ramaswamy V; Mack SC; Wang X; Leadley M; Reynaud D; Ermini L; Post M; Northcott PA; Pfister SM; Croul SE; Kool M; Korshunov A; Smith CA; Taylor MD; Rutka JT
Cancer Res; 2015 Jan; 75(1):134-46. PubMed ID: 25391241
[TBL] [Abstract][Full Text] [Related]
26. Involvement of protein kinase C-dependent mitogen-activated protein kinase p44/42 signaling pathway for cross-talk between estradiol and transforming growth factor-beta3 in increasing basic fibroblast growth factor in folliculostellate cells.
Chaturvedi K; Sarkar DK
Endocrinology; 2004 Feb; 145(2):706-15. PubMed ID: 14605008
[TBL] [Abstract][Full Text] [Related]
27. On predicting medulloblastoma metastasis by gene expression profiling.
Korenberg MJ
J Proteome Res; 2004; 3(1):91-6. PubMed ID: 14998168
[TBL] [Abstract][Full Text] [Related]
28. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs.
Martinho O; Gouveia A; Viana-Pereira M; Silva P; Pimenta A; Reis RM; Lopes JM
Histopathology; 2009 Jul; 55(1):53-62. PubMed ID: 19614767
[TBL] [Abstract][Full Text] [Related]
29. The Ras-mitogen-activated protein kinase pathway is critical for the activation of matrix metalloproteinase secretion and the invasiveness in v-crk-transformed 3Y1.
Liu E; Thant AA; Kikkawa F; Kurata H; Tanaka S; Nawa A; Mizutani S; Matsuda S; Hanafusa H; Hamaguchi M
Cancer Res; 2000 May; 60(9):2361-4. PubMed ID: 10811109
[TBL] [Abstract][Full Text] [Related]
30. In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation.
Riemenschneider MJ; Mueller W; Betensky RA; Mohapatra G; Louis DN
Am J Pathol; 2005 Nov; 167(5):1379-87. PubMed ID: 16251422
[TBL] [Abstract][Full Text] [Related]
31. EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma.
Gai QJ; Fu Z; He J; Mao M; Yao XX; Qin Y; Lan X; Zhang L; Miao JY; Wang YX; Zhu J; Yang FC; Lu HM; Yan ZX; Chen FL; Shi Y; Ping YF; Cui YH; Zhang X; Liu X; Yao XH; Lv SQ; Bian XW; Wang Y
Signal Transduct Target Ther; 2022 Feb; 7(1):33. PubMed ID: 35105853
[TBL] [Abstract][Full Text] [Related]
32. Glioma cell proliferation controlled by ERK activity-dependent surface expression of PDGFRA.
Chen D; Zuo D; Luan C; Liu M; Na M; Ran L; Sun Y; Persson A; Englund E; Salford LG; Renström E; Fan X; Zhang E
PLoS One; 2014; 9(1):e87281. PubMed ID: 24489888
[TBL] [Abstract][Full Text] [Related]
33. Genomic analysis reveals secondary glioblastoma after radiotherapy in a subset of recurrent medulloblastomas.
Phi JH; Park AK; Lee S; Choi SA; Baek IP; Kim P; Kim EH; Park HC; Kim BC; Bhak J; Park SH; Lee JY; Wang KC; Kim DS; Shim KW; Kim SH; Kim CY; Kim SK
Acta Neuropathol; 2018 Jun; 135(6):939-953. PubMed ID: 29644394
[TBL] [Abstract][Full Text] [Related]
34. Molecular Determinants of Medulloblastoma Metastasis and Leptomeningeal Dissemination.
Li M; Deng Y; Zhang W
Mol Cancer Res; 2021 May; 19(5):743-752. PubMed ID: 33608450
[TBL] [Abstract][Full Text] [Related]
35. Proteomic profiling of isogenic primary and metastatic medulloblastoma cell lines reveals differential expression of key metastatic factors.
Gu S; Chen K; Yin M; Wu Z; Wu Y
J Proteomics; 2017 May; 160():55-63. PubMed ID: 28363815
[TBL] [Abstract][Full Text] [Related]
36. Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway.
Piccaluga PP; Rossi M; Agostinelli C; Ricci F; Gazzola A; Righi S; Fuligni F; Laginestra MA; Mancini M; Sapienza MR; De Renzo A; Tazzari PL; Gibellini D; Went P; Alviano F; Zinzani PL; Bagnara GP; Inghirami G; Tripodo C; Pileri SA
Leukemia; 2014 Aug; 28(8):1687-97. PubMed ID: 24480986
[TBL] [Abstract][Full Text] [Related]
37. Whole-genome and transcriptome profiling of a metastatic thyroid-like follicular renal cell carcinoma.
Ko JJ; Grewal JK; Ng T; Lavoie JM; Thibodeau ML; Shen Y; Mungall AJ; Taylor G; Schrader KA; Jones SJM; Kollmannsberger C; Laskin J; Marra MA
Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30446580
[TBL] [Abstract][Full Text] [Related]
38. Comparison of medulloblastoma and normal neural transcriptomes identifies a restricted set of activated genes.
Boon K; Edwards JB; Siu IM; Olschner D; Eberhart CG; Marra MA; Strausberg RL; Riggins GJ
Oncogene; 2003 Oct; 22(48):7687-94. PubMed ID: 14576832
[TBL] [Abstract][Full Text] [Related]
39. High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma.
Westphal D; Garzarolli M; Sergon M; Horak P; Hutter B; Becker JC; Wiegel M; Maczey E; Blum S; Grosche-Schlee S; Rütten A; Ugurel S; Stenzinger A; Glimm H; Aust D; Baretton G; Beissert S; Fröhling S; Redler S; Surowy H; Meier F
Br J Dermatol; 2021 Dec; 185(6):1186-1199. PubMed ID: 34185311
[TBL] [Abstract][Full Text] [Related]
40. Metastatic medulloblastoma--therapeutic success through molecular target identification?
Frühwald MC; Plass C
Pharmacogenomics J; 2002; 2(1):7-10. PubMed ID: 11990385
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
